MARKET INTELLIGENCE . CONSULTING

www.techsciresearch.com

INDIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET

FORECAST & OPPORTUNITIES

FY2016 –FY2026

2

Scope of ReportProduct of Interest (POI): Active Pharmaceutical Ingredient

Review Period

FY2016 – FY2019

Base Year

FY2020

Estimated Year

FY2021

Forecast Period

FY2022 – FY2026

Year Range

Any substance or mixture of substances intended to be used in the manufacture of a drug (medicinal)

product and that, when used in the production of a drug, becomes an active ingredient of the drug

product. Such substances are intended to furnish pharmacological activity or other direct effect in the

diagnosis, cure, mitigation, treatment, or prevention of disease or to affect the structure or function of the

body.

Market Segmentation

REGION

• North

• South

• East

• West

• In-house

• Contract Manufacturing

Organizations

SOURCE

ROUTE OF

ADMINISTRATION

• Oral

• Intravenous

FORM

• Tablet

• Capsules

• Injection

• Others

DISTRIBUTION CHANNEL

• Online

• Offline

THERAPEUTIC

APPLICATION

• Cardiovascular Disease

• Skin Infections

• Neurological Disorders

• Orthopaedic Disorders

• Respiratory

• Gastrointestinal

Disorders

• Bacterial Infections

• Others

END USER

• Adult

• Pediatric

3© TechSci Research

Table of Contents

S. No. Contents Page No

1. Product Overview (Definition of product and major terminologies used in the report)

2.Research Methodology (Detailed description of the methodology used to conduct the research,Raw data backup, list of all secondary sources, List of respondents for primary surveys)

3. Impact of COVID-19 on India Active Pharmaceutical Ingredient Market

4. Executive Summary

5. Manufacturing Active Pharmaceutical Ingredient

5.1. Raw Material

5.2. Machinery

5.3. Manufacturing Methods

5.4. Contact Details of Machinery & Raw Material Supplies

6. India Active Pharmaceutical Ingredient Market Outlook

6.1. Market Size & Forecast

6.1.1. By Value & Volume

6.2. Market Share & Forecast

6.2.1.

By Drug Type (Acyclovir, Amoxicillin, Artesunate, Aspirin, Atorvastatin, Azithromycin, Betamethasone, Carbamazepine, Carbidopa, Cefixime, Cefoperazone, Ceftriaxone, Cephalexin, Ciprofloxacin, Clarithromycin, Clindamycin HCL, Clindamycin Phosphate, Dexamethasone, Diclofenac Sodium, Doxycycline, Erythromycin Stearate/Estolate, Gabapentin, Gentamycin, Levetiracetam, Levodopa, Levofloxacin, Lopinavir, Losartan, Meropenem, Metformin, Metronidazole, Neomycin, Norfloxacin, Ofloxacin, Olmesartan, Ornidazole, Oxcarbazepine, Oxytetracycline, Paracetamol, Piperacillin Tazobactam, Potassium Clavulanate, Pharma API, Rifampicin, Ritonavir, Streptomycin, Sulbactam, Sulfadiazine, Telmisartan, Tetracycline, Tinidazole, Valsartan, Vitamin B1, Vitamin B6)

6.2.2. By Source (In-house v/s Contract Manufacturing Organizations)

6.2.3. By Distribution Channel (Online v/s Offline)

6.2.4.By Therapeutic Application (Cardiovascular Disease, Skin Infections, Neurological Disorders, Orthopaedic Disorders, Respiratory, Gastrointestinal Disorders, Bacterial Infections, Others)

4© TechSci Research

Table of Contents

S. No. Contents Page No

7.2.5. By Form (Tablet, Capsule, Injection, Others)

7.2.6. By Route of Administration (Oral v/s Intravenous)

7.2.7. By End User (Adult v/s Pediatric)

7.2.8. By Region (North, East, West, South)

7.2.9. By Company (FY2020)

7.3. Product Market Map

8. Market Dynamics (This chapter assesses the major demand drivers and restraints.)

8.1. Drivers

8.2. Challenges

9.Market Trends and Developments (This section captures recent trends pertaining tomanufacturing or consumption, market movements in terms of points of production andconsumption, advancements and development)

10. Policy & Regulatory Landscape

10.1. Custom Duty & Taxes

10.2. Government Subsidy & Benefits

10.3. Relevant Policies & Regulations (GMP, USFDA, WHO Certifications)

11. Import & Export Analysis

12. Pricing Analysis

13. Demand and Supply Chain Analysis

14. Pharma API- Pricing and Sourcing Intelligence

15. India Economic Profile

16. Competitive Landscape

16.1. Competition Outlook

16.2. Company Profiles (Top 10 Leading Companies)

5© TechSci Research

Table of Contents

S. No. Contents Page No

16.2.1. Company Details

16.2.2. Product Plants & Capacity

16.2.3. Financials (If Available)

16.2.4. Captive Consumption vs Merchant Sale

16.2.5. Current & Future Plans

17.Strategic Recommendations (Based on the findings of the report strategic recommendations onhow to enter and expand market share)

18. About Us & Disclaimer

RESEARCH METHODOLOGY

7

Research Methodology

✓ Identifying Key Opinion

Leaders

✓ Questionnaire Design

✓ In-depth Interviews

Data Collection

Developing List of Respondents

Formulating Questionnaire

Market Profiling

Data Validation

Data Analysis

In-depth secondary

research was conducted

to determine top

players in the India

active pharmaceutical

ingredient market,

overall market size and

segmental market size.

In order to conduct

industry experts’

interviews, TechSci

formulated a

detailed discussion

guide.

List of industry

players and

industry specialists

was developed.

TechSci conducted

interviews with

industry experts and

industry players for

data collection and

verification.

Data obtained as

a result of

primary and

secondary

research was

validated through

rigorous

triangulation.

The data was scrutinized

using MS-Excel,

statistical tools and

internal proprietary

database to obtain

qualitative and

quantitative insights

about the India active

pharmaceutical

ingredient market.

Data

Collection

Data Filter

& AnalysisResearch &

Intelligence

Actionable

InsightsBusiness

Solution

Primary Research Desk Research Company Analysis

✓ Recent Developments

✓ Market Changing

Aspects/Dynamics

✓ Government Policies

✓ Conclusion

✓ Market Participants

✓ Key Strengths

✓ LinkedIn

✓ TechSci Internal

Database

✓ Factiva

✓ Hoovers

Paid Sources

✓ Company Websites

✓ Company Annual

Reports

✓ White Paper Study

✓ Financial Reports

✓ Investor

Presentations

✓ Regulatory Body

✓ Associations, etc.

Secondary Research

Primary Research

8

Research Methodology

Baseline Methodology

Our dedicated team of industry experts has monitored and analyzed various aspects of India active pharmaceutical ingredient market. The team has

analyzed the outlook of various segments of this market, while considering the major influencing factors such as growing use of active pharmaceutical

ingredient as an analgesic and antipyretic agent. The study includes market forecasting, which would enable our clients to take better decisions while

planning their strategy to achieve sustainability in India active pharmaceutical ingredient market.

Methodology Followed for Calculation of Market Size:

• Market Size By Value & Volume : Market size, in terms of value, for the year FY2020 was calculated based on information collected through

exhaustive secondary research and primary surveys, with various key opinion leaders/stakeholders, such as manufacturers, suppliers, channel partners,

end users, industry experts, and other industry participants.

• The team interviewed more than 40 – 50 manufacturers, suppliers, 180 – 200 end users, and 15 – 20 industry experts and other value & volume chain

stakeholders in the India active pharmaceutical ingredient market to obtain the overall market size from FY2016 to FY2020, which was validated by the

Delphi technique. Taking standard deviation into consideration, the market size was averaged out, to arrive at the market size data during FY2016-

FY2020.

• Respondents were asked about the current and future market growth rates, market shares by source, by product, by form, by route of administration,

by distribution channel, by application, by end user, by region and by company. Removing the outlier responses, the geometric mean of growth

estimates and supplier wise revenue shares generated across various segments were considered, to arrive at the final revenue shares. Revenue shares

generated across various segments were further triangulated from other stakeholders.

9

Research Methodology

Methodology Followed for Calculation of Market Shares:

Market shares by source, by product, by form, by route of administration, by distribution channel, by application, by end user, by region and by

company were calculated based on the responses received through primary surveys with industry experts, in which the respondents were asked about

the market shares or revenue generated from various segments of active pharmaceutical ingredient market. The final shares were calculated by taking

the geometric mean of the responses gathered from key opinion leaders after eliminating the outliers.

Methodology Followed for Forecasting:

• TechSci Research performed periodical checks on data collected through the surveys with logic checks and analyzed the survey results in

SPSS/Tableau Software.

• Data triangulation techniques were applied to fill the gaps and to present a more meaningful picture of the market. To forecast India active

pharmaceutical ingredient market, TechSci Research used various forecast techniques such as:

✓ Moving Average

✓ Time Series Analysis

✓ Regression Analysis

✓ Econometric and Judgmental Analysis

10

Research Methodology

TechSci Research used its own forecast tool, which is based on the growth of various allied industries in respective regions. TechSci Research also used

the impact analysis during short, medium and long term period to estimate the demand and to reach accurate market numbers. It should be noted that

the figures compiled are only for the organized market including market share data.

Partial List of Companies Interviewed Key Secondary Sources

▪ Cipla Limited

▪ Dr. Reddy’s Laboratories Ltd.

▪ Intas Pharmaceuticals Ltd.

▪ Cadila Pharmaceuticals Ltd.

▪ Sun Pharmaceutical Industries Limited

▪ Teva Pharmaceuticals Industries Ltd.

▪ Taj Pharmaceuticals Ltd.

▪ GlaxoSmithKline Pharmaceuticals Ltd.

▪ Torrent Pharmaceuticals Ltd.

▪ Fresenius Kabi India Pvt. Ltd.

▪ Indian Pharmaceutical Alliance (IPA)

▪ Indian Drug Manufacturers' Association (IDMA)

▪ Central Drugs Standard Control Organization (CDSCO)

▪ Bulk Drug Manufacturers Association of India (BDMI)

▪ World Bank

▪ TechSci Research Proprietary Database & Knowledge

Repository

▪ Company Annual Reports

▪ Industry Magazines

▪ Industry Reports

▪ News Dailies

▪ Credible Paid Databases

11

Industry Brief

According to TechSci Research report, “Global Active Pharmaceutical Ingredient Market By Type of Synthesis (Biotech (Recombinant Proteins,

Vaccines, Monoclonal Antibodies), Fermentation, Plant Extracts, Synthetic), By Type of Manufacturer (In-house, Contract), By Route of

Administration (Oral, Injectable, Topical), By Route of Administration (Oral, Injectable, Topical), By Therapeutic Application (Cardiovascular

Disease, Oncology, Neurological Disorders, Orthopedic Disorders, Respiratory, Gastrointestinal Disorders, Urology, Others), By Region,

Forecast & Opportunities, 2025”, the market is expected to undergo significant CAGR during forecast period owing to increasing prevalence of

chronic diseases such as diabetes, cancer, arthritis, bone & joint infections and pneumonia. The spike in development of new drugs using active

pharmaceutical ingredient to fight against chronic and infectious diseases are also acting as key factors driving the market. Moreover, growth in

biopharmaceutical sector and increasing geriatric population which is more prone to chronic diseases are some other important factors propelling

the growth of global active pharmaceutical ingredient market. With growing advancements in active pharmaceutical ingredient (API)

manufacturing, the market is expected to undergo significant growth in the coming years.

Additionally, the outbreak of COVID-19 and other hospital acquired infections is creating demand for active pharmaceutical ingredient for new

drug developments. They are being extensively used as antibody drug conjugates (ADCs), which are used in combination with monoclonal

antibodies and biologically active drugs for treatment of cancer. Also, increasing number of hospitals and diagnostic centers are supporting the

growth of active pharmaceutical ingredient market.

However, active pharmaceutical ingredient industry is also facing some challenges such as, shortening the drug development time and reducing

the cost of development. Moreover, lack of skilled professionals and limited availability of drugs in the developing nations may hamper the market

growth during the forecast period.

The global active pharmaceutical ingredient market is segmented based on type of synthesis, type of manufacturer, route of administration, type

of drug, therapeutic application and region. Based on type of synthesis, the market is segmented into biotech, fermentation, plant extracts and

synthetic. The biotech segment is further categorized into recombinant proteins, vaccines and monoclonal antibodies. Among them, the synthetic

segment accounted for largest market share in 2019 owing to easier procedures and easy availability of raw materials for the synthesis of active

pharmaceutical ingredient.

Based on type of manufacturer, the global active pharmaceutical ingredient market is segmented into in-house and contract. Among them, the in-

house manufacturer segment is expected to hold largest market share through 2025 as innovator companies are preferring in-house

manufacturing to avail economic benefits and prevent technology leakage.

Major players operating in the global active pharmaceutical ingredient market include Abbott Laboratories, Inc., Teva Pharmaceutical Industries

Ltd., Cipla Inc., Dr. Reddy's Laboratories Ltd., Mylan N.V., Bristol-Myers Squibb Company, Boehringer Ingelheim GmbH, Aurobindo Pharma Ltd,

Merck & Co., Inc., Sun Pharmaceutical Industries Ltd., Albemarle Corporation, GlaxoSmithKline Plc, Novartis AG, F. Hoffmann-La Roche AG,

Pfizer Inc., Sanofi, AstraZeneca, Eli Lilly, Aspen and AbbVie Inc. The market players are adopting growth strategies like agreements,

partnerships and collaborations to strengthen their market positions.

“North America dominates the global active pharmaceutical ingredient market followed by Europe as the two regions are witnessing increasing

government focus on generic drugs. Further, increasing technological advancements in manufacturing of APIs is providing lucrative opportunity

for manufacturers in North America. Also, the presence of adequate manufacturing units in developed nations are propelling API market growth,”

said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

12

Sample Data - Snapshot

5.00 6.00 7.00 8.00 9.00 10.00 11.00 12.00 13.00 14.00 15.00

10.00 20.00 30.00 40.00 50.00 60.00 70.00 80.00 90.00 100.00 110.00

FY2016 FY2020 FY2021E FY2026F

By Value (USD Million)

By Volume (Million Units)

India Active Pharmaceutical Ingredient Market Size, By Value (USD Million) & Volume (Million Units), FY2016–FY2026F

CAGR By Value & Volume

XX%CAGR By Value & Volume

YY%

India Active Pharmaceutical Ingredient Market Share, By Source,

By Value, 2015–2025F

60%

60%

60%

60%

60%

60%

60%

60%

60%

60%

60%

40%

40%

40%

40%

40%

40%

40%

40%

40%

40%

40%

FY2016

FY2017

FY2018

FY2019

FY2020

FY2021E

FY2022F

FY2023F

FY2024F

FY2025F

FY2026F

In-house Contract Manufacturing Organizations

India Active Pharmaceutical Ingredient Market Share, By End User, By

Value, 2015–2025F

60%

60%

60%

60%

60%

60%

60%

60%

60%

60%

60%

40%

40%

40%

40%

40%

40%

40%

40%

40%

40%

40%

FY2016

FY2017

FY2018

FY2019

FY2020

FY2021E

FY2022F

FY2023F

FY2024F

FY2025F

FY2026F

Adult Pediatric

India Active Pharmaceutical Ingredient Market Share, By Distribution Channel, By Value, 2015–2025F

60%60%60%60%60%60%60%60%60%60%60%

40%40%40%40%40%40%40%40%40%40%40%

FY2016

FY2018

FY2020

FY2022F

FY2024F

FY2026F

Online Offline

13

Report Ordering

License Type Price

Electronic Access - Single User License $2950

Electronic Access - Multi-User License $3750

Custom Research License $7500

Report Price

To View Sample OR Purchase Report

Report Name: INDIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET

FORECAST & OPPORTUNITIES

FY2016 –FY2026

About Us & Disclaimer

TechSci Research is a global market research and consulting company with offices in the US, UK and India. TechSci Research provides market research reports in number of areas

to organizations. The company uses innovative business models that focus on improving productivity, while ensuring creation of high-quality reports. The proprietary forecasting

models use various analyses of both industry-specific and macroeconomic variables on a state-by-state basis to produce a unique ‘bottom-up’ model of a country, regional and

global industry prospects. Combined with the detailed analysis of company activity and industry trends, the result is a uniquely rich evaluation of the opportunities available in the

market.

Related Reports

• India Streptomycin Market By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet, Capsule and Injection), By Route of

Administration (Oral v/s Intravenous), By Type of Manufacturing Process (Natural, Synthetic and Semi-synthetic), By Distribution Channel (Online v/s

Offline), By Application (Tuberculosis, meningitis, throat Infection, endocarditis, brucellosis, plague, tularemia, rat bite fever and Others), By End User

(Adult v/s Paediatric), By Company, By Region, Forecast & Opportunities, FY2026

• India Potassium Clavulanate Market By Composition (Single, Combinational), By Route of Administration (Oral v/s Intravenous), By Form (Tablet,

Capsule, Syrup, Injection), By Distribution Channel (Online v/s Offline), By Source (In-house v/s Contract Manufacturing Organizations), By

Application (Respiratory Tract Infections, Skin Infections, UTI, Otitis media, Gynaecological infections, Bone and Joint Infections and Others), By End

User (Adult v/s Pediatric), By Company, By Region, Forecast & Opportunities, FY2026

The contents of this report are based on information generally available to the public from sources believed to be reliable. No representation is made that it is timely, accurate or

complete. TechSci Research has taken due care and caution in compilation of data as this has been obtained from various sources including which it considers reliable and first hand.

However, TechSci Research does not guarantee the accuracy, adequacy or completeness of any information and it is not responsible for any errors or omissions or for the results

obtained from the use of such information and especially states that it has no financial liability whatsoever to the subscribers / users of this report. The information herein, together

with all estimates and forecasts, can change without notice. All the figures provided in this document are indicative of relative market size and are strictly for client’s internal

consumption. Usage of the same for purpose other than internal will require prior approval of TechSci Research.

TechSci Research – North America708 Third Avenue, Manhattan,

New York, United States

Tel: +1- 646- 360- 1656

Email: sales@techsciresearch.com

www.techsciresearch.com

Disclaimer

TechSci Research – Europe54, Old brook, Bretton,

Peterborough,

United Kingdom

Email: sales@techsciresearch.com

www.techsciresearch.com

TechSci Research – Asia-PacificB – 44, Sector – 57, Noida, National Capital

Region, U.P. - India

Tel: +91-120-4523900

Email: sales@techsciresearch.com

www.techsciresearch.com